Am J Perinatol 2017; 34(14): 1470-1476
DOI: 10.1055/s-0037-1603654
Commentary
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Critical Congenital Heart Disease Screening in NICU: Need for Revision and Standardization

Nithi Fernandes
1   Division of Neonatology, Women & Children's Hospital at Buffalo, Buffalo, New York
,
Billie Short
2   Division of Neonatology, Children's National Medical Center, Washington, District of Columbia
,
Veena Manja
3   Division of Epidemiology, McMaster University, Ontario, Canada
4   Division of Cardiology, Veterans Affairs Medical Center, Buffalo, New York
,
Satyan Lakshminrusimha
1   Division of Neonatology, Women & Children's Hospital at Buffalo, Buffalo, New York
› Author Affiliations
Further Information

Publication History

24 December 2016

01 May 2017

Publication Date:
14 June 2017 (online)

Abstract

Screening for critical congenital heart disease (CCHD) at 24 to 48 hours after birth or before discharge in newborn nurseries using pulse oximetry is effective and is mandated by most states. However, there is no established protocol for screening in a neonatal intensive care unit (NICU), a setting where neonates are continuously monitored by pulse oximetry, hypoxemia from noncardiac causes is common, and echocardiograms are frequently obtained. CCHDs with hypoxemia are suspected on admission and investigated with an echocardiogram before a formal screen in the NICU. The most common CCHD lesions missed in a NICU setting are secondary targets of the screen, such as aortic arch anomalies (coarctation or interrupted aortic arch). The sensitivity of the current pulse oximeter–based CCHD screen to diagnose aortic arch anomalies is low. Given that infants are monitored with continuous pulse oximetry and frequent examinations, novel revisions to the current screening methods are necessary to detect asymptomatic NICU infants with aortic arch anomalies before discharge. Exclusions (whom to screen), technique (how to screen), and timing (when to screen) for primary and secondary targets of CCHD in the NICU are not known and require further research.

 
  • References

  • 1 Oster ME, Lee KA, Honein MA, Riehle-Colarusso T, Shin M, Correa A. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics 2013; 131 (05) e1502-e1508
  • 2 Dawson AL, Cassell CH, Riehle-Colarusso T. , et al. Factors associated with late detection of critical congenital heart disease in newborns. Pediatrics 2013; 132 (03) e604-e611
  • 3 Mahle WT, Newburger JW, Matherne GP. , et al; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Interdisciplinary Council on Quality of Care and Outcomes Research; American Academy of Pediatrics Section on Cardiology And Cardiac Surgery; Committee On Fetus And Newborn. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics 2009; 124 (02) 823-836
  • 4 Kemper AR, Mahle WT, Martin GR. , et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics 2011; 128 (05) e1259-e1267
  • 5 Mahle WT, Martin GR, Beekman III RH, Morrow WR. ; Section on Cardiology and Cardiac Surgery Executive Committee. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics 2012; 129 (01) 190-192
  • 6 Guyatt G, Rennie D, Meade MO, Cook DJ. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed. New York, NY: McGraw-Hill; 2015
  • 7 Thangaratinam S, Brown K, Zamora J, Khan KS, Ewer AK. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet 2012; 379 (9835): 2459-2464
  • 8 Ailes EC, Gilboa SM, Honein MA, Oster ME. Estimated number of infants detected and missed by critical congenital heart defect screening. Pediatrics 2015; 135 (06) 1000-1008
  • 9 Chang RK, Gurvitz M, Rodriguez S. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med 2008; 162 (10) 969-974
  • 10 National Perinatal Information Center. Special care nursery admissions (2011). Available at: https://www.marchofdimes.org/peristats/pdfdocs/nicu_summary_final.pdf . Accessed April 25, 2017
  • 11 Manja V, Lakshminrusimha S, Cook DJ. Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis. JAMA Pediatr 2015; 169 (04) 332-340
  • 12 Suresh GK. Pulse oximetry screening for critical congenital heart disease in neonatal intensive care units. J Perinatol 2013; 33 (08) 586-588
  • 13 Iyengar H, Kumar P, Kumar P. Pulse-oximetry screening to detect critical congenital heart disease in the neonatal intensive care unit. Pediatr Cardiol 2014; 35 (03) 406-410
  • 14 Goetz EM, Magnuson KM, Eickhoff JC, Porte MA, Hokanson JS. Pulse oximetry screening for critical congenital heart disease in the neonatal intensive care unit. J Perinatol 2016; 36 (01) 52-56
  • 15 Manja V, Mathew B, Carrion V, Lakshminrusimha S. Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit. J Perinatol 2015; 35 (01) 67-71
  • 16 Jegatheesan P, Song D, Angell C, Devarajan K, Govindaswami B. Oxygen saturation nomogram in newborns screened for critical congenital heart disease. Pediatrics 2013; 131 (06) e1803-e1810
  • 17 Fernandes N, Lakshminrusimha S, Sacilowski M, Rochez D. Detection of Arch Defects with Blood Pressure Measurements at 24–48 Hours. Philadelphia, PA: Eastern Society for Pediatric Research; 2017
  • 18 Van Naarden Braun K, Grazel R, Koppel R. , et al. Evaluation of critical congenital heart defects screening in the Neonatal Intensive Care Unit (NICU). Abstract presented at: Eastern Society for Pediatric Research Conference; March 25, 2017; Philadelphia, PA. https://www.aps-spr.org/regions/espr/meetings/default.asp
  • 19 Mathur NB, Gupta A, Kurien S. Pulse Oximetry Screening to Detect Cyanotic Congenital Heart Disease in Sick Neonates in a Neonatal Intensive Care Unit. Indian Pediatr 2015; 52 (09) 769-772
  • 20 Hu XJ, Zhao QM, Ma XJ. , et al. Pulse oximetry could significantly enhance the early detection of critical congenital heart disease in neonatal intensive care units. Acta Paediatr 2016; 105 (11) e499-e505
  • 21 de-Wahl Granelli A, Wennergren M, Sandberg K. , et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ 2009; 338: a3037 . Doi: 10.1136/bmj.a3037
  • 22 Ewer AK, Middleton LJ, Furmston AT. , et al; PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet 2011; 378 (9793): 785-794
  • 23 Meberg A, Brügmann-Pieper S, Due Jr R. , et al. First day of life pulse oximetry screening to detect congenital heart defects. J Pediatr 2008; 152 (06) 761-765
  • 24 Riede FT, Wörner C, Dähnert I, Möckel A, Kostelka M, Schneider P. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine--results from a prospective multicenter study. Eur J Pediatr 2010; 169 (08) 975-981
  • 25 Patankar N, Fernandes N, Kumar K, Manja V, Lakshminrusimha S. Does measurement of four-limb blood pressures at birth improve detection of aortic arch anomalies?. J Perinatol 2016; 36 (05) 376-380
  • 26 Crossland DS, Furness JC, Abu-Harb M, Sadagopan SN, Wren C. Variability of four limb blood pressure in normal neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89 (04) F325-F327
  • 27 Boelke KL, Hokanson JS. Blood pressure screening for critical congenital heart disease in neonates. Pediatr Cardiol 2014; 35 (08) 1349-1355
  • 28 Rahiala E, Tikanoja T. Suspicion of aortic coarctation in an outpatient clinic: how should blood pressure measurements be performed?. Clin Physiol 2001; 21 (01) 100-104
  • 29 Reşit Kavsaoğlu A, Polat K, Recep Bozkurt M. A novel feature ranking algorithm for biometric recognition with PPG signals. Comput Biol Med 2014; 49: 1-14
  • 30 Palmeri L, Gradwohl G, Nitzan M. , et al. Photoplethysmographic waveform characteristics of newborns with coarctation of the aorta. J Perinatol 2017; 37 (01) 77-80
  • 31 Granelli Ad, Ostman-Smith I. Noninvasive peripheral perfusion index as a possible tool for screening for critical left heart obstruction. Acta Paediatr 2007; 96 (10) 1455-1459
  • 32 Schena F, Picciolli I, Agosti M. , et al; Neonatal Cardiology Study Group of the Italian Society of Neonatology. Perfusion Index and Pulse Oximetry Screening for Congenital Heart Defects. J Pediatr 2017; 183: 74-79.e1
  • 33 Oster ME, Aucott SW, Glidewell J. , et al. Lessons Learned From Newborn Screening for Critical Congenital Heart Defects. Pediatrics 2016; 137 (05) e20154573 . Doi: 10.1542/peds.2015-4573